7-BROMO-2,4-DICHLORO-6-FLUOROQUINAZOLINE, 95.0%, 1g

4-Bromopyrazolo[1,5-a]pyridine, 95.0%, 100mg

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, 95.0%, 1g

4-(5-Ethyl-2-methoxy-phenyl)-4-hydroxy-butyric acid, 95.0%, 1g

2-[(4-Fluoro-benzyl)-methyl-amino]-ethanol, 95.0%, 500mg

3-Bromo-biphenyl, 98.0%, 1kg

MonoMethacryloxypropyl terminated polydimethylsiloxane asymmetric 50-80Cst, 100g

1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 1g

{1-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]ethyl}amine trifluoroacetate, 95.0%, 5g

4-Iodobiphenyl>97.0%(GC)5g

methyl 5-amino-1-(2,4-dichlorophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

2-(2-Fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(S)-(9H-Fluoren-9-yl)methyl (1-chloro-3-methyl-1-oxobutan-2-yl)carbamate, 95.0%, 10g